OpiCalc Logo

OpiCalc

--- Clinical Tools

Logo
OpiCalc
ABCD2 ScoreACR CriteriaASCVD RiskBurch-Wartofsky Point ScaleCHA2DS2-VAScCURB-65Corrected SodiumFENaGlasgow-Blatchford ScoreHAS-BLEDHEART ScoreISTH DIC ScoreLights CriteriaMaddrey DFNEWS2NRS-2002Osmolality GapPERC RulePadua VTE ScoreRCRI (Lee Score)Ransons CriteriaRevised Geneva ScoreTTKGWells DVT ScoreWells PE Score

Clinical Evidence and Methodology

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Use

  • All adult patients within 24h of hospital admission (ESPEN mandate)
  • Identify patients requiring proactive nutritional intervention before clinical deterioration
  • Mandatory documentation in many NHS, EU, and Australian accreditation frameworks
  • Patients with chronic disease, recent surgery, poor oral intake, or unexplained weight loss

Who to Screen

All medical and surgical inpatients ≥ 18 years. Re-screen weekly if initial screen is negative. If BMI > 30 with no other risk factors, patient scores 0 on initial screen but monitor given obesity-related malnutrition risk.

CLINICAL INSIGHT

How it Works

Step 1 — Initial Screen (4 YES/NO Questions)

  • BMI < 20.5?
  • Weight loss in last 3 months?
  • Reduced dietary intake in last week?
  • Patient severely ill (ICU)?

Step 2 — Full Scoring (if any Step 1 = YES)

  • Nutritional status: 0 (normal) to 3 (severe malnutrition or minimal intake)
  • Disease severity: 0 (no disease) to 3 (ICU patient ± APACHE > 10)
  • Age ≥ 70 years: +1 point

Score Interpretation

Total score ≥ 3 = At nutritional risk. Initiate individualised nutritional support plan. Score < 3 = Not currently at risk. Re-screen weekly.

CLINICAL INSIGHT

Practical Pearls

NRS-2002 vs MUST

  • NRS-2002: Preferred for HOSPITALISED adult patients. Validated in 128 RCTs.
  • MUST: Better for community/outpatient settings and GP practices.
  • SNAQ: Shorter 4-item tool validated for hospital screening with comparable performance.
  • MNA (Mini Nutritional Assessment): Best validated tool for elderly populations (≥ 65 years).

Nutritional Intervention Targets

  • Protein target: 1.2–1.5 g/kg/day (higher in severe disease, burns, surgery)
  • Calorie target: 25–30 kcal/kg/day (avoid overfeeding in critically ill)
  • Enteral nutrition preferred over parenteral when gut functional
  • Initiate EN within 24–48h of ICU admission in ventilated patients
CLINICAL INSIGHT

Next Steps

Score ≥ 3 — Actions

  • Dietitian referral within 24h.
  • Document nutritional plan in patient notes.
  • Prescribe oral nutritional supplements (ONS) as initial step.
  • For swallowing difficulty or inadequate oral intake: nasogastric tube + enteral feeds.
  • For non-functional gut: parenteral nutrition via central access (PICC or CVC).

Score < 3 — Actions

  • Continue to encourage normal oral intake.
  • Re-screen weekly or if clinical status changes.
  • Reassess if prolonged NPO status, new infection, or surgery planned.

Complementary Tools

CLINICAL INSIGHT

Evidence Base

Validation Study

Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials.

Kondrup J, Rasmussen HH, Hamberg O, Stanga Z; Ad Hoc ESPEN Working Group.Clinical Nutrition.2003
CLINICAL INSIGHT

Background

ESPEN Development — 2003

NRS-2002 was developed by Kondrup and colleagues for the European Society for Clinical Nutrition and Metabolism (ESPEN). Unlike other tools that rely on clinician gestalt, NRS-2002 was uniquely derived by checking whether patients in 128 published RCTs who would have scored ≥ 3 actually benefited from nutritional intervention. This evidence-first approach makes it the most rigorously constructed nutritional screening tool in clinical use.

NRS-2002

NRS-2002 — Nutritional Risk Screening: ESPEN-recommended tool for all hospitalised patients. Score ≥ 3 = nutritional risk. Mandatory screening within 24h of admission in many NHS/EU hospitals.

Step 1 — Initial Screening

No criteria met — Re-screen weekly or if clinical status changes.

No clinical reference data available.